Work

NCI MATCH (EAY131) arm Z1D: Retrospective evaluation of attributions of adverse events experienced on nivolumab in patients with MSI-high tumors.

Year: 2024

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2024.42.16_suppl.e14711

Authors: Darah Christine Davidson, Nilofer Saba Azad, Howard Streicher, Lyndsay Harris, Lisa McShane, Elad Sharon

Institutions: Sidney Kimmel Comprehensive Cancer Center, National Institutes of Health, National Cancer Institute, Dana-Farber Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4399325013

Cites:

Cited by: 1

Related to: 10